STAAR Surgical Co Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs
STAAR Surgical Co (STAA) had Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs of -$525.00 thousand as of 2014-01-03, per its 10-K filed 2014-03-12.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts · last filed 2014-03-12
- 2014-01-03: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs -$525.00K.
- 2012-12-28: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs -$605.00K.
| Period end | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs |
|---|---|
| 2014-01-03 | -$525.00K 10-K · filed 2014-03-12 |
| 2012-12-28 | -$605.00K 10-K · filed 2014-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |